Posted On: 08/17/2015 7:46:54 PM
Post# of 72446
The trial has enrolled five lung cancer patients according to the ASCO poster.
Cohort 9, 450 mg/m2, 69, female, SCLC
Cohort 1, 20 mg/m2, 69, female, SCLC
Cohort 7, 215 mg/m2, 67, male, NSCLC
Cohort 6, 165, 73, male, NSCLC
Cohort 10, 750 mg/m2, 63, male, metastatic pulmonary basal cell
The fact that DF enrolled someone in the latest cohort tells me that they are seeing something from the previous cohorts. Similar to what they are doing with the ovarian cancer patients.
Cohort 9, 450 mg/m2, 69, female, SCLC
Cohort 1, 20 mg/m2, 69, female, SCLC
Cohort 7, 215 mg/m2, 67, male, NSCLC
Cohort 6, 165, 73, male, NSCLC
Cohort 10, 750 mg/m2, 63, male, metastatic pulmonary basal cell
The fact that DF enrolled someone in the latest cohort tells me that they are seeing something from the previous cohorts. Similar to what they are doing with the ovarian cancer patients.
(0)
(0)
